Scientific publications

Our scientific publications bring you facts and figures about healthcare in Switzerland. We use anonymised insurance data to examine the links between therapy results and the resources deployed, allowing us to draw conclusions about their effectiveness and efficiency.

Note: the publications are presented in their original language and are only available in that language.

Selected Tab: {"active":true,"title":"2024"}

Discrepancy between antibiotic pack sizes and guideline recommendations: a real-world analysis based on claims data

Are integrated care models associated with improved drug safety in Swiss primary care? An observational analysis using healthcare claims data

Prescriber-level surveillance of outpatient antimicrobial consumption to enable targeted antimicrobial stewardship: a nationwide observational study, Switzerland, 2015 to 2022

Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non-melanoma Skin Cancer: An Interrupted Time-Series Analysis Using Swiss Claims Data

Dispensed drugs during pregnancy in outpatient care between 2015 and 2021 in Switzerland: a retrospective analysis of Swiss healthcare claims data

Real-world treatment patterns and medical costs of prostate cancer patients in Switzerland - a claims data analysis

Use of metamizole and other non-opioid analgesics in Switzerland between 2014 and 2019: an observational study using a large health insurance claims database

Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort

Development and internal validation of a prediction model for long-term opioid use - an analysis of insurance claims data

Do you have questions?

We're here to help.